Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897726163> ?p ?o ?g. }
- W2897726163 endingPage "9907" @default.
- W2897726163 startingPage "9889" @default.
- W2897726163 abstract "The kinase ataxia telangiectasia mutated and rad3 related (ATR) is a key regulator of the DNA-damage response and the apical kinase which orchestrates the cellular processes that repair stalled replication forks (replication stress) and associated DNA double-strand breaks. Inhibition of repair pathways mediated by ATR in a context where alternative pathways are less active is expected to aid clinical response by increasing replication stress. Here we describe the development of the clinical candidate 2 (AZD6738), a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. Compound 2 was developed improving aqueous solubility and eliminating CYP3A4 time-dependent inhibition starting from the earlier described inhibitor 1 (AZ20). The clinical candidate 2 has favorable human PK suitable for once or twice daily dosing and achieves biologically effective exposure at moderate doses. Compound 2 is currently being tested in multiple phase I/II trials as an anticancer agent." @default.
- W2897726163 created "2018-10-26" @default.
- W2897726163 creator A5009408120 @default.
- W2897726163 creator A5015517140 @default.
- W2897726163 creator A5023168024 @default.
- W2897726163 creator A5040373927 @default.
- W2897726163 creator A5043718319 @default.
- W2897726163 creator A5050840048 @default.
- W2897726163 creator A5055277039 @default.
- W2897726163 creator A5055415882 @default.
- W2897726163 creator A5059413107 @default.
- W2897726163 creator A5063242294 @default.
- W2897726163 creator A5064572702 @default.
- W2897726163 creator A5069830252 @default.
- W2897726163 creator A5076477541 @default.
- W2897726163 creator A5077720573 @default.
- W2897726163 date "2018-10-22" @default.
- W2897726163 modified "2023-10-10" @default.
- W2897726163 title "Discovery and Characterization of AZD6738, a Potent Inhibitor of Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Kinase with Application as an Anticancer Agent" @default.
- W2897726163 cites W1580878752 @default.
- W2897726163 cites W1942954494 @default.
- W2897726163 cites W1964554012 @default.
- W2897726163 cites W1967630574 @default.
- W2897726163 cites W1973825719 @default.
- W2897726163 cites W1977368300 @default.
- W2897726163 cites W1980792687 @default.
- W2897726163 cites W1982514936 @default.
- W2897726163 cites W1986421405 @default.
- W2897726163 cites W1988698602 @default.
- W2897726163 cites W1989651533 @default.
- W2897726163 cites W1992849882 @default.
- W2897726163 cites W2005087793 @default.
- W2897726163 cites W2005328285 @default.
- W2897726163 cites W2012657024 @default.
- W2897726163 cites W2013895149 @default.
- W2897726163 cites W2027630134 @default.
- W2897726163 cites W2036314575 @default.
- W2897726163 cites W2039286264 @default.
- W2897726163 cites W2046216305 @default.
- W2897726163 cites W2049453025 @default.
- W2897726163 cites W2050022747 @default.
- W2897726163 cites W2053365908 @default.
- W2897726163 cites W2061197983 @default.
- W2897726163 cites W2075221169 @default.
- W2897726163 cites W2081873746 @default.
- W2897726163 cites W2107632586 @default.
- W2897726163 cites W2112416492 @default.
- W2897726163 cites W2113927644 @default.
- W2897726163 cites W2121960436 @default.
- W2897726163 cites W2126345597 @default.
- W2897726163 cites W2154119901 @default.
- W2897726163 cites W2161138700 @default.
- W2897726163 cites W2173456459 @default.
- W2897726163 cites W2177777322 @default.
- W2897726163 cites W2196056082 @default.
- W2897726163 cites W2201979800 @default.
- W2897726163 cites W2270474355 @default.
- W2897726163 cites W2314919359 @default.
- W2897726163 cites W2319489769 @default.
- W2897726163 cites W2330335659 @default.
- W2897726163 cites W2333415105 @default.
- W2897726163 cites W2343685960 @default.
- W2897726163 cites W2414273841 @default.
- W2897726163 cites W2527041732 @default.
- W2897726163 cites W2549803280 @default.
- W2897726163 cites W2559890484 @default.
- W2897726163 cites W2561432266 @default.
- W2897726163 cites W2570952233 @default.
- W2897726163 cites W2580220347 @default.
- W2897726163 cites W2587696209 @default.
- W2897726163 cites W2591465210 @default.
- W2897726163 cites W2606114462 @default.
- W2897726163 cites W2609630616 @default.
- W2897726163 cites W2614107005 @default.
- W2897726163 cites W2732809609 @default.
- W2897726163 cites W2885866858 @default.
- W2897726163 cites W2886880700 @default.
- W2897726163 cites W2972789187 @default.
- W2897726163 cites W4246732618 @default.
- W2897726163 doi "https://doi.org/10.1021/acs.jmedchem.8b01187" @default.
- W2897726163 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30346772" @default.
- W2897726163 hasPublicationYear "2018" @default.
- W2897726163 type Work @default.
- W2897726163 sameAs 2897726163 @default.
- W2897726163 citedByCount "186" @default.
- W2897726163 countsByYear W28977261632019 @default.
- W2897726163 countsByYear W28977261632020 @default.
- W2897726163 countsByYear W28977261632021 @default.
- W2897726163 countsByYear W28977261632022 @default.
- W2897726163 countsByYear W28977261632023 @default.
- W2897726163 crossrefType "journal-article" @default.
- W2897726163 hasAuthorship W2897726163A5009408120 @default.
- W2897726163 hasAuthorship W2897726163A5015517140 @default.
- W2897726163 hasAuthorship W2897726163A5023168024 @default.
- W2897726163 hasAuthorship W2897726163A5040373927 @default.
- W2897726163 hasAuthorship W2897726163A5043718319 @default.
- W2897726163 hasAuthorship W2897726163A5050840048 @default.
- W2897726163 hasAuthorship W2897726163A5055277039 @default.